Vol. 73 No. 1, September 2009

Index

• Legal autopsies: assessing the performance of judges and lawyers through the window of leading contract cases.
• Annoyancetech vigilante torts and policy.
• The extrapolation of defendants' liabilities under CPLR Article 16 where the plaintiff is contributorily negligent: an update toward resolving a perceived ambiguity of CPLR 1601.
• CPLR 3211(a) (7): demurrer or merits-testing device?
• Ethics of lawyer social networking.
• To (b) or not to (b): is that the question? Twenty-first century Schizoid plans under section 403(b) of the Internal Revenue Code.
• Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
• Playing the odds or playing God? Limiting parental ability to create disabled children through preimplantation genetic diagnosis.
• A safe harbor for drugs made offshore: the Federal Circuit renders the Bolar Amendment available in [section] 337 actions in Amgen v. U.S. International Trade Commission.